Coronary CT
Diagnostic TestCoronary CT evaluation
NCT Number: NCT06036901
A total of 9269 adults who received CCTA scans for coronary disease evaluation during a general medical checkup at the Health Screening and Promotion Center in Asan Medical Center, Seoul, Korea between January 2007 and December 2011 were initially selected. All participants were provided with information about the potential benefits and risks of CCTA and made the decision to undergo the procedure at their own expense. They were also informed that their clinical and radiological data would be used for this study and gave their consent. Of these individuals, 7129 agreed to participate, and 6343 were enrolled in this CCTA registry.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Coronary CT evaluation
Time frame: 5 years
Diameter stenosis >50% in any coronary artery by coronary CT angiography
Time frame: 5 years
Time frame: 5 years
any death caused by a cardiovascular problem or if there was no identified cause of death
Time frame: 5 years
Number of participants with an increase in cardiac enzyme above the upper reference limit with ischemic symptoms or signs.
Time frame: 5 years
Number of participants with any percutaneous or surgical revascularization procedure during follow-up.
CardioVascular Research Foundation, Korea
Other
Assessment of Coronary Artery Disease in Asymptomatic Population Undergoing Coronary Computed Tomography Angiography: A Single Center, Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03917199
Arterial Occlusive Diseases, Arteriosclerosis
Warsaw, Poland
View Trial DetailsNCT07291609
Arterial Occlusive Diseases, Arteriosclerosis
Caserta, Italy
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial Details